Savings for Americans and American Innovation: U.S. and UK Agree on Drug Pricing Deal

from Freedomcast · host Center For Individual Freedom

Phil Kerpen, President and Founder of American Commitment, discusses the recent drug-pricing deal negotiated by the Trump administration with the United Kingdom, the multiple benefits the agreement will have for Americans and drug innovation, why taxpayer subsidies to health insurers will not lower healthcare costs, and why price controls for credit card transactions are a bad idea.

Episode metadata supplied by the publisher feed · Published Dec 4, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Savings for Americans and American Innovation: U.S. and UK Agree on Drug Pricing Deal

0:00 23:33

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Freedomcast?

This episode is 23 minutes long.

When was this Freedomcast episode published?

This episode was published on December 4, 2025.

Can I download this Freedomcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!